Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells

Published:2013-05 Issue:2 Volume:435 Page:188-194
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Han Zhiqiang,Feng Jing,Hong Zhenya,Chen Lijuan,Li Wei,Liao Shujie,Wang Xiaoli,Ji Teng,Wang Shixuan,Ma Ding,Chen Gang,Gao Qinglei

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference33 articles.

1. Molecular approaches to personalizing management of ovarian cancer;Bast;Ann. Oncol.,2011

2. The STATs of cancer: new molecular targets come of age;Yu;Nat. Rev. Cancer,2004

3. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential;Meinhold-Heerlein;Oncogene,2005

4. Signal transducers and activators of transcription 3 pathway activation in drugresistant ovarian cancer;Duan;Clin. Cancer Res.,2006

5. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis;Rosen;Cancer,2006

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter;Cancers;2023-11-29

2. The role of microRNA-induced apoptosis in diverse radioresistant cancers;Cellular Signalling;2023-04

3. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer;Drug Resistance Updates;2022-12

4. The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers;Cancers;2022-09-27

5. Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations;Cancers;2022-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3